This suggests that the antioxidant effect of verbascoside might be regulated through the increase in SIRT1 activity, leading to treatment of obesity and related metabolic disorders through AMPK activation. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.